Cancer Supportive Care Drugs Market, Global Outlook and Forecast 2022-2028

February 2022 | 65 pages | ID: C123925AA518EN
Market Monitor Global

Abstracts

Cancer Supportive care also known as palliative care is focused on relieving patients from side effects of cancer therapies. In cancer palliative care, supportive drugs are used to lessen the side effects of cancer treatments. In many cases cancer treatments need to be stopped or doses need to lowered due various reasons such as low blood cell counts. In such cases, cancer supportive drugs such as CSFs enable patients to continue with cancer treatments as well as in other cases, it also allows higher doses of cancer therapies. Cancer being one of the leading causes of death worldwide, there has been increasing focus on cancer treatments. Many cancer treatments comes with various side effects such as fatigue, pain, fertility problems, depression, heartburn, sexual problems, bone diseases and other side effects.

This report contains market size and forecasts of Cancer Supportive Care Drugs in Global, including the following market information:

Global Cancer Supportive Care Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cancer Supportive Care Drugs market was valued at 23800 million in 2021 and is projected to reach US$ 28330 million by 2028, at a CAGR of 2.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Granulocyte-Colony Stimulating Factors (G-CSFS) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cancer Supportive Care Drugs include Amgen, Johnson & Johnson, Novartis, Baxter International, Fagron Group, Teva Pharmaceuticals Industries, F.Hoffmann La-Roche Ltd, Apr Applied Pharma Science Research and Acacia Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Supportive Care Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cancer Supportive Care Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cancer Supportive Care Drugs Market Segment Percentages, by Type, 2021 (%)

• Granulocyte-Colony Stimulating Factors (G-CSFS)
• Erythropoietin-Stimulating Agents (ESAS)
• Antiemetics
• Bisphosphonates
• Opioids
• Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)
• Others

Global Cancer Supportive Care Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cancer Supportive Care Drugs Market Segment Percentages, by Application, 2021 (%)

• Breast Cancer
• Lung Cancer
• Melanoma
• Prostate Cancer
• Others

Global Cancer Supportive Care Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cancer Supportive Care Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cancer Supportive Care Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cancer Supportive Care Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Amgen
• Johnson & Johnson
• Novartis
• Baxter International
• Fagron Group
• Teva Pharmaceuticals Industries
• F.Hoffmann La-Roche Ltd
• Apr Applied Pharma Science Research
• Acacia Pharma
• Kyowa Hakko Kirin
• Helsinn Healthcare
• Heron Pharma
• Merck & Co. Inc
• Sanofi

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cancer Supportive Care Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cancer Supportive Care Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CANCER SUPPORTIVE CARE DRUGS OVERALL MARKET SIZE

2.1 Global Cancer Supportive Care Drugs Market Size: 2021 VS 2028
2.2 Global Cancer Supportive Care Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cancer Supportive Care Drugs Players in Global Market
3.2 Top Global Cancer Supportive Care Drugs Companies Ranked by Revenue
3.3 Global Cancer Supportive Care Drugs Revenue by Companies
3.4 Top 3 and Top 5 Cancer Supportive Care Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cancer Supportive Care Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Supportive Care Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Cancer Supportive Care Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cancer Supportive Care Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cancer Supportive Care Drugs Market Size Markets, 2021 & 2028
  4.1.2 Granulocyte-Colony Stimulating Factors (G-CSFS)
  4.1.3 Erythropoietin-Stimulating Agents (ESAS)
  4.1.4 Antiemetics
  4.1.5 Bisphosphonates
  4.1.6 Opioids
  4.1.7 Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)
  4.1.8 Others
4.2 By Type - Global Cancer Supportive Care Drugs Revenue & Forecasts
  4.2.1 By Type - Global Cancer Supportive Care Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Cancer Supportive Care Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Cancer Supportive Care Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cancer Supportive Care Drugs Market Size, 2021 & 2028
  5.1.2 Breast Cancer
  5.1.3 Lung Cancer
  5.1.4 Melanoma
  5.1.5 Prostate Cancer
  5.1.6 Others
5.2 By Application - Global Cancer Supportive Care Drugs Revenue & Forecasts
  5.2.1 By Application - Global Cancer Supportive Care Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Cancer Supportive Care Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Cancer Supportive Care Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cancer Supportive Care Drugs Market Size, 2021 & 2028
6.2 By Region - Global Cancer Supportive Care Drugs Revenue & Forecasts
  6.2.1 By Region - Global Cancer Supportive Care Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Cancer Supportive Care Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Cancer Supportive Care Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cancer Supportive Care Drugs Revenue, 2017-2028
  6.3.2 US Cancer Supportive Care Drugs Market Size, 2017-2028
  6.3.3 Canada Cancer Supportive Care Drugs Market Size, 2017-2028
  6.3.4 Mexico Cancer Supportive Care Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cancer Supportive Care Drugs Revenue, 2017-2028
  6.4.2 Germany Cancer Supportive Care Drugs Market Size, 2017-2028
  6.4.3 France Cancer Supportive Care Drugs Market Size, 2017-2028
  6.4.4 U.K. Cancer Supportive Care Drugs Market Size, 2017-2028
  6.4.5 Italy Cancer Supportive Care Drugs Market Size, 2017-2028
  6.4.6 Russia Cancer Supportive Care Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Cancer Supportive Care Drugs Market Size, 2017-2028
  6.4.8 Benelux Cancer Supportive Care Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cancer Supportive Care Drugs Revenue, 2017-2028
  6.5.2 China Cancer Supportive Care Drugs Market Size, 2017-2028
  6.5.3 Japan Cancer Supportive Care Drugs Market Size, 2017-2028
  6.5.4 South Korea Cancer Supportive Care Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Cancer Supportive Care Drugs Market Size, 2017-2028
  6.5.6 India Cancer Supportive Care Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cancer Supportive Care Drugs Revenue, 2017-2028
  6.6.2 Brazil Cancer Supportive Care Drugs Market Size, 2017-2028
  6.6.3 Argentina Cancer Supportive Care Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cancer Supportive Care Drugs Revenue, 2017-2028
  6.7.2 Turkey Cancer Supportive Care Drugs Market Size, 2017-2028
  6.7.3 Israel Cancer Supportive Care Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Cancer Supportive Care Drugs Market Size, 2017-2028
  6.7.5 UAE Cancer Supportive Care Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Amgen
  7.1.1 Amgen Corporate Summary
  7.1.2 Amgen Business Overview
  7.1.3 Amgen Cancer Supportive Care Drugs Major Product Offerings
  7.1.4 Amgen Cancer Supportive Care Drugs Revenue in Global Market (2017-2022)
  7.1.5 Amgen Key News
7.2 Johnson & Johnson
  7.2.1 Johnson & Johnson Corporate Summary
  7.2.2 Johnson & Johnson Business Overview
  7.2.3 Johnson & Johnson Cancer Supportive Care Drugs Major Product Offerings
  7.2.4 Johnson & Johnson Cancer Supportive Care Drugs Revenue in Global Market (2017-2022)
  7.2.5 Johnson & Johnson Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis Cancer Supportive Care Drugs Major Product Offerings
  7.3.4 Novartis Cancer Supportive Care Drugs Revenue in Global Market (2017-2022)
  7.3.5 Novartis Key News
7.4 Baxter International
  7.4.1 Baxter International Corporate Summary
  7.4.2 Baxter International Business Overview
  7.4.3 Baxter International Cancer Supportive Care Drugs Major Product Offerings
  7.4.4 Baxter International Cancer Supportive Care Drugs Revenue in Global Market (2017-2022)
  7.4.5 Baxter International Key News
7.5 Fagron Group
  7.5.1 Fagron Group Corporate Summary
  7.5.2 Fagron Group Business Overview
  7.5.3 Fagron Group Cancer Supportive Care Drugs Major Product Offerings
  7.5.4 Fagron Group Cancer Supportive Care Drugs Revenue in Global Market (2017-2022)
  7.5.5 Fagron Group Key News
7.6 Teva Pharmaceuticals Industries
  7.6.1 Teva Pharmaceuticals Industries Corporate Summary
  7.6.2 Teva Pharmaceuticals Industries Business Overview
  7.6.3 Teva Pharmaceuticals Industries Cancer Supportive Care Drugs Major Product Offerings
  7.6.4 Teva Pharmaceuticals Industries Cancer Supportive Care Drugs Revenue in Global Market (2017-2022)
  7.6.5 Teva Pharmaceuticals Industries Key News
7.7 F.Hoffmann La-Roche Ltd
  7.7.1 F.Hoffmann La-Roche Ltd Corporate Summary
  7.7.2 F.Hoffmann La-Roche Ltd Business Overview
  7.7.3 F.Hoffmann La-Roche Ltd Cancer Supportive Care Drugs Major Product Offerings
  7.7.4 F.Hoffmann La-Roche Ltd Cancer Supportive Care Drugs Revenue in Global Market (2017-2022)
  7.7.5 F.Hoffmann La-Roche Ltd Key News
7.8 Apr Applied Pharma Science Research
  7.8.1 Apr Applied Pharma Science Research Corporate Summary
  7.8.2 Apr Applied Pharma Science Research Business Overview
  7.8.3 Apr Applied Pharma Science Research Cancer Supportive Care Drugs Major Product Offerings
  7.8.4 Apr Applied Pharma Science Research Cancer Supportive Care Drugs Revenue in Global Market (2017-2022)
  7.8.5 Apr Applied Pharma Science Research Key News
7.9 Acacia Pharma
  7.9.1 Acacia Pharma Corporate Summary
  7.9.2 Acacia Pharma Business Overview
  7.9.3 Acacia Pharma Cancer Supportive Care Drugs Major Product Offerings
  7.9.4 Acacia Pharma Cancer Supportive Care Drugs Revenue in Global Market (2017-2022)
  7.9.5 Acacia Pharma Key News
7.10 Kyowa Hakko Kirin
  7.10.1 Kyowa Hakko Kirin Corporate Summary
  7.10.2 Kyowa Hakko Kirin Business Overview
  7.10.3 Kyowa Hakko Kirin Cancer Supportive Care Drugs Major Product Offerings
  7.10.4 Kyowa Hakko Kirin Cancer Supportive Care Drugs Revenue in Global Market (2017-2022)
  7.10.5 Kyowa Hakko Kirin Key News
7.11 Helsinn Healthcare
  7.11.1 Helsinn Healthcare Corporate Summary
  7.11.2 Helsinn Healthcare Business Overview
  7.11.3 Helsinn Healthcare Cancer Supportive Care Drugs Major Product Offerings
  7.11.4 Helsinn Healthcare Cancer Supportive Care Drugs Revenue in Global Market (2017-2022)
  7.11.5 Helsinn Healthcare Key News
7.12 Heron Pharma
  7.12.1 Heron Pharma Corporate Summary
  7.12.2 Heron Pharma Business Overview
  7.12.3 Heron Pharma Cancer Supportive Care Drugs Major Product Offerings
  7.12.4 Heron Pharma Cancer Supportive Care Drugs Revenue in Global Market (2017-2022)
  7.12.5 Heron Pharma Key News
7.13 Merck & Co. Inc
  7.13.1 Merck & Co. Inc Corporate Summary
  7.13.2 Merck & Co. Inc Business Overview
  7.13.3 Merck & Co. Inc Cancer Supportive Care Drugs Major Product Offerings
  7.13.4 Merck & Co. Inc Cancer Supportive Care Drugs Revenue in Global Market (2017-2022)
  7.13.5 Merck & Co. Inc Key News
7.14 Sanofi
  7.14.1 Sanofi Corporate Summary
  7.14.2 Sanofi Business Overview
  7.14.3 Sanofi Cancer Supportive Care Drugs Major Product Offerings
  7.14.4 Sanofi Cancer Supportive Care Drugs Revenue in Global Market (2017-2022)
  7.14.5 Sanofi Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cancer Supportive Care Drugs Market Opportunities & Trends in Global Market
Table 2. Cancer Supportive Care Drugs Market Drivers in Global Market
Table 3. Cancer Supportive Care Drugs Market Restraints in Global Market
Table 4. Key Players of Cancer Supportive Care Drugs in Global Market
Table 5. Top Cancer Supportive Care Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cancer Supportive Care Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cancer Supportive Care Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cancer Supportive Care Drugs Product Type
Table 9. List of Global Tier 1 Cancer Supportive Care Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Supportive Care Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cancer Supportive Care Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cancer Supportive Care Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cancer Supportive Care Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cancer Supportive Care Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cancer Supportive Care Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cancer Supportive Care Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cancer Supportive Care Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cancer Supportive Care Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cancer Supportive Care Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cancer Supportive Care Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cancer Supportive Care Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cancer Supportive Care Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cancer Supportive Care Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cancer Supportive Care Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cancer Supportive Care Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cancer Supportive Care Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cancer Supportive Care Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cancer Supportive Care Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cancer Supportive Care Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Amgen Corporate Summary
Table 31. Amgen Cancer Supportive Care Drugs Product Offerings
Table 32. Amgen Cancer Supportive Care Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Johnson & Johnson Corporate Summary
Table 34. Johnson & Johnson Cancer Supportive Care Drugs Product Offerings
Table 35. Johnson & Johnson Cancer Supportive Care Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Cancer Supportive Care Drugs Product Offerings
Table 38. Novartis Cancer Supportive Care Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Baxter International Corporate Summary
Table 40. Baxter International Cancer Supportive Care Drugs Product Offerings
Table 41. Baxter International Cancer Supportive Care Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Fagron Group Corporate Summary
Table 43. Fagron Group Cancer Supportive Care Drugs Product Offerings
Table 44. Fagron Group Cancer Supportive Care Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Teva Pharmaceuticals Industries Corporate Summary
Table 46. Teva Pharmaceuticals Industries Cancer Supportive Care Drugs Product Offerings
Table 47. Teva Pharmaceuticals Industries Cancer Supportive Care Drugs Revenue (US$, Mn), (2017-2022)
Table 48. F.Hoffmann La-Roche Ltd Corporate Summary
Table 49. F.Hoffmann La-Roche Ltd Cancer Supportive Care Drugs Product Offerings
Table 50. F.Hoffmann La-Roche Ltd Cancer Supportive Care Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Apr Applied Pharma Science Research Corporate Summary
Table 52. Apr Applied Pharma Science Research Cancer Supportive Care Drugs Product Offerings
Table 53. Apr Applied Pharma Science Research Cancer Supportive Care Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Acacia Pharma Corporate Summary
Table 55. Acacia Pharma Cancer Supportive Care Drugs Product Offerings
Table 56. Acacia Pharma Cancer Supportive Care Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Kyowa Hakko Kirin Corporate Summary
Table 58. Kyowa Hakko Kirin Cancer Supportive Care Drugs Product Offerings
Table 59. Kyowa Hakko Kirin Cancer Supportive Care Drugs Revenue (US$, Mn), (2017-2022)
Table 60. Helsinn Healthcare Corporate Summary
Table 61. Helsinn Healthcare Cancer Supportive Care Drugs Product Offerings
Table 62. Helsinn Healthcare Cancer Supportive Care Drugs Revenue (US$, Mn), (2017-2022)
Table 63. Heron Pharma Corporate Summary
Table 64. Heron Pharma Cancer Supportive Care Drugs Product Offerings
Table 65. Heron Pharma Cancer Supportive Care Drugs Revenue (US$, Mn), (2017-2022)
Table 66. Merck & Co. Inc Corporate Summary
Table 67. Merck & Co. Inc Cancer Supportive Care Drugs Product Offerings
Table 68. Merck & Co. Inc Cancer Supportive Care Drugs Revenue (US$, Mn), (2017-2022)
Table 69. Sanofi Corporate Summary
Table 70. Sanofi Cancer Supportive Care Drugs Product Offerings
Table 71. Sanofi Cancer Supportive Care Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cancer Supportive Care Drugs Segment by Type in 2021
Figure 2. Cancer Supportive Care Drugs Segment by Application in 2021
Figure 3. Global Cancer Supportive Care Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cancer Supportive Care Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cancer Supportive Care Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Supportive Care Drugs Revenue in 2021
Figure 8. By Type - Global Cancer Supportive Care Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cancer Supportive Care Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cancer Supportive Care Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cancer Supportive Care Drugs Revenue Market Share, 2017-2028
Figure 12. US Cancer Supportive Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cancer Supportive Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cancer Supportive Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cancer Supportive Care Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Cancer Supportive Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Cancer Supportive Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cancer Supportive Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cancer Supportive Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cancer Supportive Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cancer Supportive Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cancer Supportive Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cancer Supportive Care Drugs Revenue Market Share, 2017-2028
Figure 24. China Cancer Supportive Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cancer Supportive Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cancer Supportive Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cancer Supportive Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Cancer Supportive Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cancer Supportive Care Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Cancer Supportive Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cancer Supportive Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cancer Supportive Care Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Cancer Supportive Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cancer Supportive Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cancer Supportive Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cancer Supportive Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Amgen Cancer Supportive Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Johnson & Johnson Cancer Supportive Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Cancer Supportive Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Baxter International Cancer Supportive Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Fagron Group Cancer Supportive Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Teva Pharmaceuticals Industries Cancer Supportive Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. F.Hoffmann La-Roche Ltd Cancer Supportive Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Apr Applied Pharma Science Research Cancer Supportive Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Acacia Pharma Cancer Supportive Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Kyowa Hakko Kirin Cancer Supportive Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Helsinn Healthcare Cancer Supportive Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Heron Pharma Cancer Supportive Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Merck & Co. Inc Cancer Supportive Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Sanofi Cancer Supportive Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)